Clinical Trial Update: Functional Precision Oncology to Predict, Prevent, and Treat Early Metastatic Recurrence of TNBC [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial from the University of Utah uses functional precision oncology to predict, prevent, and treat early metastatic recurrence in triple-neg…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Snippet

Sponsor: University of Utah | Conditions: Breast Cancer Recurrent | Phase 2 | Status: RECRUITING